Sectors With The Most Picks
Biotechnology
| Outperform | |||
|---|---|---|---|
| Ticker | Company Name | Pick Date | Score |
| View all Tickers in Tag | |||
| ACAD | ACADIA Pharmaceuticals, Inc. | 11/29/2011 | +1,229.19 |
| SRPT | Sarepta Therapeutics | 5/15/2013 | +620.65 |
| DNDN | Dendreon Corp | 3/26/2009 | +500.75 |
| ANDS.DL | Anadys Pharmaceuticals, Inc. | 9/12/2011 | +458.23 |
| REGN | Regeneron Pharmaceuticals, Inc. | 5/15/2013 | +337.47 |
| GALE | Galena Biopharma, Inc. | 10/13/2011 | +304.51 |
| ALNY | Alnylam Pharmaceuticals, Inc. | 5/15/2013 | +255.98 |
| INSM | Insmed, Inc. | 4/30/2012 | +255.42 |
| CLDX | Celldex Therapeutics, Inc. | 5/15/2013 | +254.96 |
| KERX | Keryx Biopharmaceuticals | 6/14/2012 | +233.78 |
| CPHD | Cepheid | 3/3/2010 | +209.06 |
| CLSN | Celsion Corp | 11/28/2011 | +201.91 |
| EXAS | EXACT Sciences Corp | 11/4/2010 | +193.61 |
| AMRI | Albany Molecular Resh Inc | 9/12/2011 | +180.44 |
| ARNA | Arena Pharmaceuticals, Inc. | 5/9/2012 | +146.93 |
| EVTCY | Evotec AG | 3/3/2010 | +144.62 |
| ONXX | Onyx Pharmaceuticals, Inc. | 5/15/2013 | +142.90 |
| MDVN | Medivation, Inc. | 5/15/2013 | +134.66 |
| NPSP | NPS Pharmaceuticals, Inc. | 11/22/2011 | +132.70 |
| AFFX | Affymetrix, Inc. | 3/6/2009 | +128.44 |
| LGND | Ligand Pharmaceuticals, Inc. | 3/3/2010 | +126.31 |
| ILMN | Illumina Inc | 10/7/2011 | +121.06 |
| VVUS | VIVUS, Inc. | 1/10/2012 | +120.89 |
| SGMO | Sangamo Biosciences, Inc. | 5/15/2013 | +119.87 |
| VRTX | Vertex Pharmaceuticals, Inc. | 5/15/2013 | +118.63 |
| SNTA | Synta Pharmaceuticals Corp. | 6/7/2010 | +112.16 |
| TSRX | Trius Therapeutics, Inc. | 11/5/2010 | +110.61 |
| A | Agilent Technologies, Inc. | 3/3/2010 | +102.36 |
| GILD | Gilead Sciences, Inc. | 5/15/2013 | +91.10 |
| BIIB | Biogen Idec, Inc. | 5/15/2013 | +90.74 |
| LXRX | Lexicon Pharmaceuticals, Inc. | 10/5/2011 | +87.51 |
| CRME | Cardiome Pharma Corp | 7/30/2009 | +86.58 |
| IDIX | Idenix Pharmaceuticals, Inc. | 8/25/2009 | +79.82 |
| SNTA | Synta Pharmaceuticals Corp. | 9/21/2009 | +77.68 |
| ASTX | Astex Pharmaceuticals, Inc. | 1/3/2013 | +76.40 |
| SNTA | Synta Pharmaceuticals Corp. | 10/5/2011 | +73.49 |
| CELG | Celgene Corp | 5/15/2013 | +69.03 |
| ELN | Elan Corp, plc (ADR) | 11/16/2010 | +67.71 |
| ARIA | Ariad Pharmaceuticals, Inc. | 10/13/2011 | +66.76 |
| PBTH | PROLOR Biotech, Inc. | 3/3/2010 | +64.97 |
| ISIS | ISIS Pharmaceuticals, Inc. | 5/15/2013 | +62.50 |
| DD | E.I. du Pont de Nemours & Company | 1/15/2010 | +62.10 |
| CRTX | Cornerstone Therapeutics Inc. | 1/3/2013 | +60.37 |
| BDSI | BioDelivery Sciences International, Inc. | 4/4/2012 | +59.03 |
| RPTP | Raptor Pharmaceuticals Corp. | 4/27/2011 | +56.32 |
| MITI | Micromet, Inc. | 4/29/2011 | +54.97 |
| CYTK | Cytokinetics Inc | 1/3/2013 | +54.65 |
| BMRN | BioMarin Pharmaceutical, Inc. | 5/15/2013 | +52.30 |
| AMGN | Amgen, Inc. | 5/15/2013 | +52.26 |
| ARIA | Ariad Pharmaceuticals, Inc. | 11/4/2010 | +51.53 |
| ISIS | ISIS Pharmaceuticals, Inc. | 11/11/2011 | +50.11 |
| AFFX | Affymetrix, Inc. | 5/28/2009 | +50.06 |
| ALKS | Alkermes, Inc. | 1/3/2013 | +48.25 |
| SQNM | Sequenom, Inc. | 3/3/2010 | +43.69 |
| DYAX | Dyax Corp. | 3/14/2011 | +43.20 |
| DEPO | DepoMed, Inc. | 3/3/2010 | +43.01 |
| FOLD | Amicus Therapeutics, Inc. | 6/29/2010 | +42.94 |
| ACHN | Achillion Pharmaceuticals, Inc. | 10/5/2011 | +42.72 |
| QCOR | Questcor Pharmaceuticals | 10/11/2011 | +41.20 |
| IDIX | Idenix Pharmaceuticals, Inc. | 9/7/2010 | +36.19 |
| TTHI | Transition Therapeutics Inc. | 1/3/2011 | +35.98 |
| MITI | Micromet, Inc. | 6/4/2009 | +34.77 |
| SGEN | Seattle Genetics, Inc. | 10/11/2011 | +32.67 |
| GALE | Galena Biopharma, Inc. | 4/5/2012 | +32.10 |
| LXRX | Lexicon Pharmaceuticals, Inc. | 11/16/2010 | +31.35 |
| QCOR | Questcor Pharmaceuticals | 11/12/2012 | +31.07 |
| MDCO | The Medicines Company | 1/3/2013 | +30.21 |
| LIFE | Life Technologies Corporation | 11/4/2010 | +29.86 |
| ACOR | Acorda Therapeutics, Inc. | 10/15/2009 | +29.83 |
| ARRY | Array BioPharma, Inc. | 3/4/2013 | +29.24 |
| KERX | Keryx Biopharmaceuticals | 1/28/2013 | +28.80 |
| DNDN | Dendreon Corp | 7/6/2010 | +28.70 |
| IMUC | ImmunoCellular Therapeutics, Ltd. | 10/21/2011 | +27.12 |
| INCY | Incyte Corp | 3/3/2010 | +26.34 |
| PBTH | PROLOR Biotech, Inc. | 10/5/2011 | +24.44 |
| MYGN | Myriad Genetics, Inc. | 10/12/2011 | +23.81 |
| ELN | Elan Corp, plc (ADR) | 10/26/2009 | +23.72 |
| ABBV | AbbVie Inc. | 1/3/2013 | +23.63 |
| PCYC | Pharmacyclics, Inc. | 9/14/2012 | +23.41 |
| SLXP | Salix Pharmaceuticals, Ltd. | 1/3/2013 | +23.29 |
| MKGAY | Merck KGAA | 11/4/2010 | +22.90 |
| ACHN | Achillion Pharmaceuticals, Inc. | 5/5/2011 | +21.13 |
| RIGL | Rigel Pharmaceuticals, Inc. | 10/19/2009 | +20.11 |
| GALE | Galena Biopharma, Inc. | 6/10/2010 | +20.09 |
| GHDX | Genomic Health, Inc. | 1/3/2013 | +19.75 |
| MIPIQ | Molecular Insight Pharmaceuticals, Inc. | 8/9/2010 | +17.58 |
| ONXX | Onyx Pharmaceuticals, Inc. | 11/4/2010 | +17.09 |
| TROV | TrovaGene, Inc. | 4/22/2013 | +16.95 |
| VNDA | Vanda Pharmaceuticals, Inc. | 10/28/2009 | +16.71 |
| RHHBY | Roche Holding Ltd. (ADR) | 11/4/2010 | +16.39 |
| LXRX | Lexicon Pharmaceuticals, Inc. | 6/28/2010 | +15.74 |
| SNSS | Sunesis Pharmaceuticals, Inc. | 1/3/2013 | +15.61 |
| INCY | Incyte Corp | 7/6/2010 | +15.12 |
| XNPT | XenoPort, Inc. | 3/3/2010 | +15.11 |
| MDVN | Medivation, Inc. | 11/4/2010 | +15.05 |
| VNDA | Vanda Pharmaceuticals, Inc. | 7/6/2010 | +14.96 |
| TRGT | Targacept , Inc. | 12/3/2009 | +14.89 |
| SVNT | Savient Pharmaceuticals Inc | 9/8/2009 | +14.56 |
| DVAX | Dynavax Technologies Corp | 2/25/2013 | +14.54 |
| AMRI | Albany Molecular Resh Inc | 6/8/2010 | +14.47 |
| EXEL | Exelixis, Inc. | 5/28/2009 | +14.13 |
| IDIX | Idenix Pharmaceuticals, Inc. | 2/10/2011 | +14.02 |
| ITMN | InterMune, Inc. | 5/5/2010 | +13.75 |
| SRPT | Sarepta Therapeutics | 7/19/2010 | +13.39 |
| IMGN | ImmunoGen, Inc. | 4/20/2010 | +12.39 |
| GPRO | Gen-Probe, Inc. | 4/20/2010 | +12.22 |
| STEM | StemCells, Inc. | 8/24/2010 | +12.21 |
| EXEL | Exelixis, Inc. | 7/1/2010 | +11.57 |
| INSM | Insmed, Inc. | 6/25/2010 | +11.28 |
| MNKD | MannKind Corp | 10/15/2009 | +11.21 |
| VRTX | Vertex Pharmaceuticals, Inc. | 11/4/2010 | +10.66 |
| RIGL | Rigel Pharmaceuticals, Inc. | 4/20/2010 | +10.05 |
| ALXN | Alexion Pharmaceuticals, Inc. | 10/11/2011 | +10.03 |
| DNDN | Dendreon Corp | 8/23/2010 | +10.00 |
| BIIB | Biogen Idec, Inc. | 10/15/2009 | +9.42 |
| GHDX | Genomic Health, Inc. | 11/4/2010 | +9.20 |
| LXRX | Lexicon Pharmaceuticals, Inc. | 6/11/2010 | +8.79 |
| SLXP | Salix Pharmaceuticals, Ltd. | 10/12/2011 | +8.78 |
| SQNM | Sequenom, Inc. | 6/8/2010 | +8.16 |
| LXRX | Lexicon Pharmaceuticals, Inc. | 5/27/2011 | +7.89 |
| BIIB | Biogen Idec, Inc. | 7/23/2010 | +5.75 |
| INFI | Infinity Pharmaceuticals, Inc. | 11/4/2010 | +5.66 |
| PIP | PharmAthene, Inc. | 8/3/2011 | +5.08 |
| ILMN | Illumina Inc | 10/15/2009 | +5.02 |
| IMGN | ImmunoGen, Inc. | 7/28/2010 | +4.64 |
| QCOR | Questcor Pharmaceuticals | 6/18/2012 | +2.46 |
| INCY | Incyte Corp | 10/12/2011 | +2.15 |
| CCXI | ChemoCentryx, Inc. | 9/10/2012 | +1.25 |
| SNTA | Synta Pharmaceuticals Corp. | 6/18/2012 | +0.95 |
| CRIS | Curis, Inc. | 1/3/2013 | +0.70 |
| ILMN | Illumina Inc | 5/14/2013 | +0.48 |
| PPHM | Peregrine Pharmaceuticals | 12/7/2011 | -0.32 |
| VRML | Vermillion, Inc. | 10/12/2011 | -0.87 |
| HALO | Halozyme Therapeutics, Inc. | 11/4/2010 | -0.92 |
| ECYT | Endocyte, Inc. | 7/26/2011 | -1.14 |
| NVS | Novartis AG (ADR) | 12/8/2009 | -2.80 |
| VPHM | ViroPharma, Inc. | 1/3/2013 | -4.15 |
| ARWR | Arrowhead Research Corp | 1/3/2013 | -4.38 |
| CBST | Cubist Pharmaceuticals, Inc. | 10/11/2011 | -7.47 |
| LXRX | Lexicon Pharmaceuticals, Inc. | 6/18/2012 | -7.54 |
| IMGN | ImmunoGen, Inc. | 7/26/2011 | -8.91 |
| QGEN | QIAGEN N.V. | 9/12/2011 | -9.01 |
| JAZZ | Jazz Pharmaceuticals, Inc. | 1/3/2013 | -9.06 |
| FOLD | Amicus Therapeutics, Inc. | 11/11/2011 | -10.83 |
| ACOR | Acorda Therapeutics, Inc. | 11/11/2010 | -16.45 |
| NAVB | Navidea Biopharmaceuticals, Inc. | 9/11/2012 | -18.70 |
| TKMR | Tekmira Pharmaceuticals | 1/3/2013 | -20.89 |
| CPHD | Cepheid | 4/16/2012 | -21.11 |
| ANTH | Anthera Pharmaceuticals Inc | 1/3/2013 | -23.60 |
| INFI | Infinity Pharmaceuticals, Inc. | 5/14/2013 | -25.16 |
| PDLI | PDL BioPharma, Inc. | 11/4/2010 | -26.63 |
| EXEL | Exelixis, Inc. | 11/11/2011 | -28.58 |
| ARIA | Ariad Pharmaceuticals, Inc. | 6/18/2012 | -30.50 |
| SQNM | Sequenom, Inc. | 11/11/2011 | -31.50 |
| ALNY | Alnylam Pharmaceuticals, Inc. | 11/19/2010 | -31.58 |
| SIGA | SIGA Technologies, Inc. | 10/7/2011 | -31.93 |
| TKMR | Tekmira Pharmaceuticals | 3/28/2011 | -32.61 |
| VRML | Vermillion, Inc. | 5/10/2011 | -33.54 |
| SGMO | Sangamo Biosciences, Inc. | 7/26/2011 | -35.11 |
| VRTX | Vertex Pharmaceuticals, Inc. | 5/27/2011 | -35.17 |
| SNTA | Synta Pharmaceuticals Corp. | 1/3/2011 | -35.73 |
| FOLD | Amicus Therapeutics, Inc. | 10/12/2011 | -35.98 |
| PIP | PharmAthene, Inc. | 9/23/2011 | -36.96 |
| GNVC | GenVec, Inc. | 2/1/2011 | -37.06 |
| SVNT | Savient Pharmaceuticals Inc | 9/12/2011 | -37.23 |
| CHTP | Chelsea Therapeutics International Ltd. | 4/3/2012 | -37.52 |
| MON | Monsanto Company | 11/4/2010 | -37.58 |
| ARNA | Arena Pharmaceuticals, Inc. | 6/18/2012 | -38.18 |
| FOLD | Amicus Therapeutics, Inc. | 7/14/2011 | -38.20 |
| ABPI | Accentia Biopharmaceuticals, Inc. | 12/6/2010 | -38.29 |
| ISIS | ISIS Pharmaceuticals, Inc. | 5/19/2010 | -38.42 |
| GNOM | Complete Genomics | 7/26/2011 | -38.43 |
| XNPT | XenoPort, Inc. | 5/4/2011 | -38.46 |
| MYGN | Myriad Genetics, Inc. | 11/4/2010 | -38.54 |
| NVAX | Novavax, Inc. | 6/2/2010 | -39.70 |
| ANAC | Anacor Pharmaceuticals | 3/23/2011 | -40.00 |
| SIGA | SIGA Technologies, Inc. | 7/26/2011 | -40.40 |
| OPTR | Optimer Pharmaceuticals Inc | 3/3/2010 | -40.59 |
| VVUS | VIVUS, Inc. | 11/4/2010 | -40.62 |
| XOMA | XOMA Limited | 3/23/2011 | -41.34 |
| TTHI | Transition Therapeutics Inc. | 4/14/2011 | -41.72 |
| ISIS | ISIS Pharmaceuticals, Inc. | 10/1/2009 | -42.33 |
| LXRX | Lexicon Pharmaceuticals, Inc. | 9/15/2009 | -43.37 |
| SQNM | Sequenom, Inc. | 1/7/2011 | -44.71 |
| NVAX | Novavax, Inc. | 9/29/2009 | -44.78 |
| EXEL | Exelixis, Inc. | 3/3/2010 | -45.12 |
| BDSI | BioDelivery Sciences International, Inc. | 11/4/2010 | -45.25 |
| EXEL | Exelixis, Inc. | 6/6/2011 | -47.17 |
| DNDN | Dendreon Corp | 8/4/2011 | -47.19 |
| SRPT | Sarepta Therapeutics | 9/15/2010 | -47.54 |
| IDRA | Idera Pharmaceuticals, Inc. | 10/19/2010 | -47.59 |
| PBTH | PROLOR Biotech, Inc. | 6/25/2010 | -48.32 |
| DSCO | Discovery Laboratories, Inc. | 12/29/2010 | -49.70 |
| AMRI | Albany Molecular Resh Inc | 9/9/2010 | -49.73 |
| PIP | PharmAthene, Inc. | 10/5/2011 | -50.30 |
| GALE | Galena Biopharma, Inc. | 3/16/2010 | -51.18 |
| NABI.DL | Biota Pharmaceuticals, Inc. | 6/10/2011 | -51.78 |
| AFFY | Affymax, Inc. | 3/8/2013 | -53.53 |
| SVNT | Savient Pharmaceuticals Inc | 1/7/2011 | -54.41 |
| BVTIQ | Biovest Intl Inc | 12/3/2010 | -54.52 |
| DSCO | Discovery Laboratories, Inc. | 2/16/2011 | -55.04 |
| BLRX | BioLineRx Ltd. ADR | 4/4/2012 | -55.13 |
| CRME | Cardiome Pharma Corp | 8/11/2010 | -55.27 |
| ALNY | Alnylam Pharmaceuticals, Inc. | 11/4/2010 | -58.43 |
| AFFX | Affymetrix, Inc. | 7/12/2010 | -58.55 |
| EBS | Emergent BioSolutions, Inc. | 10/5/2011 | -58.63 |
| MYRX | Myriad Pharmaceuticals Inc | 11/4/2010 | -60.69 |
| ARNA | Arena Pharmaceuticals, Inc. | 9/15/2010 | -61.47 |
| TRGT | Targacept , Inc. | 11/11/2011 | -61.67 |
| TRGT | Targacept , Inc. | 5/9/2011 | -62.08 |
| AVNR | AVANIR Pharmaceuticals | 11/3/2010 | -63.21 |
| GALE | Galena Biopharma, Inc. | 12/15/2010 | -63.99 |
| AMRI | Albany Molecular Resh Inc | 3/26/2009 | -67.19 |
| MNTA | Momenta Pharmaceuticals, Inc. | 11/4/2010 | -67.77 |
| ARRY | Array BioPharma, Inc. | 11/4/2010 | -68.86 |
| QGEN | QIAGEN N.V. | 11/4/2010 | -69.37 |
| ANDS.DL | Anadys Pharmaceuticals, Inc. | 8/9/2010 | -70.63 |
| DNDN | Dendreon Corp | 11/3/2011 | -74.04 |
| ARQL | ArQule, Inc. | 11/4/2010 | -75.40 |
| FCSCD | Fibrocell Science Inc | 7/26/2011 | -75.70 |
| RIGL | Rigel Pharmaceuticals, Inc. | 8/26/2011 | -76.83 |
| CBLI | Cleveland BioLabs, Inc. | 6/30/2011 | -77.76 |
| VVUS | VIVUS, Inc. | 6/18/2012 | -78.67 |
| PGNX | Progenics Pharmaceuticals, Inc. | 11/4/2010 | -82.04 |
| BCRX | BioCryst Pharmaceuticals, Inc. | 3/14/2011 | -82.06 |
| TLON | Talon Therapeutics | 5/18/2011 | -86.62 |
| GNOM | Complete Genomics | 10/7/2011 | -87.28 |
| CYCC | Cyclacel Pharmaceuticals Inc | 7/1/2011 | -89.75 |
| GERN | Geron Corp | 10/10/2011 | -91.64 |
| GERN | Geron Corp | 11/4/2010 | -92.45 |
| AFFY | Affymax, Inc. | 11/4/2010 | -93.31 |
| ITMN | InterMune, Inc. | 10/11/2011 | -96.39 |
| SQNM | Sequenom, Inc. | 3/11/2009 | -97.44 |
| MRNA | Marina Biotech | 1/31/2011 | -97.60 |
| ZIOP | ZIOPHARM Oncology | 1/7/2011 | -99.59 |
| ONTY | Oncothyreon, Inc. | 7/26/2011 | -100.23 |
| SVNT | Savient Pharmaceuticals Inc | 11/11/2011 | -102.18 |
| CLSN | Celsion Corp | 12/5/2012 | -105.16 |
| CRME | Cardiome Pharma Corp | 9/12/2011 | -105.78 |
| ANTH | Anthera Pharmaceuticals Inc | 7/19/2010 | -108.64 |
| PTIE | Pain Therapeutics, Inc. | 11/4/2010 | -108.94 |
| PARD | PONIARD PHARMACEUT COM STK USD0.02 | 3/3/2010 | -110.88 |
| PYMXQ | Polymedix Inc | 9/15/2010 | -122.33 |
Pharmaceuticals
63 Outperform
0 Underperform
Life Sciences Tools and Services
39 Outperform
0 Underperform
Metals and Mining
35 Outperform
0 Underperform
Communications Equipment
29 Outperform
0 Underperform
Commercial Banks
29 Outperform
0 Underperform
Semiconductors and Semiconductor Equipment
27 Outperform
0 Underperform
Internet Software and Services
25 Outperform
0 Underperform
Oil, Gas and Consumable Fuels
24 Outperform
0 Underperform
Software
23 Outperform
0 Underperform
Electronic Equipment, Instruments and Components
22 Outperform
0 Underperform
Chemicals
20 Outperform
0 Underperform
Computers and Peripherals
19 Outperform
0 Underperform
Diversified Telecommunication Services
18 Outperform
0 Underperform
Insurance
16 Outperform
0 Underperform
Capital Markets
15 Outperform
0 Underperform
Emerging Markets Funds
11 Outperform
0 Underperform
Diversified Financial Services
10 Outperform
0 Underperform
Specialty Retail
9 Outperform
0 Underperform
Automobiles
9 Outperform
0 Underperform
Healthcare Equipment and Supplies
8 Outperform
0 Underperform
Electrical Equipment
8 Outperform
0 Underperform
European Region Funds
7 Outperform
0 Underperform
Media
7 Outperform
0 Underperform
Internet and Catalog Retail
5 Outperform
0 Underperform
Wireless Telecommunication Services
4 Outperform
0 Underperform
Electric Utilities
2 Outperform
0 Underperform
Latin American Funds
1 Outperform
0 Underperform
Commercial Services and Supplies
0 Outperform
0 Underperform













RSS Headlines
Fool UK